Novartis Pharma B.V.
Location
Noord-Holland
Founded
1948-02-10
Website
Risk Signals
21161 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Drugs, Drug Proprietaries, and Druggists' Sundries), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Novartis Pharma B.V.
Live alerts from global media, monitored by Business Radar
2025-05-31 (endpoints.news)
Patient dies in Rocket gene therapy trial; Lilly's $1B deal for a non-opioid pain biotech; A new dawn for psychedelics? ; and more
Rocket's gene therapy trial on hold after patient death; Lilly acquires SiteOne for up to $1B; Compass Pathways awaits Phase 3 data; Novartis wins Regulus bidding war for $1.7B
Read more
2025-01-31 (wallstreet-online.de)
Optimism for 2025: Novartis increases sales and operational profit in double digits - more dividends! - 31.01.2025
Novartis achieved one of the strongest financial results in its history in the 2024 financial year. Novartis has one of the strongest in the 2024 financial year ...
Read more
2024-11-13 (biospace.com)
Schrödinger Reports Third Quarter 2024 Financial Results
Schrödinger to Receive $150 Million Upfront for New Multi-Target Collaboration with Novartis
Read more
2024-11-04 (enfarma.lat)
Novartis releases its financial results
Release. Commenting on the third quarter 2024 results, Vas Narasimhan, CEO of Novartis, said: “Novartis achieved another quarter of strong operating performance in the third quarter, with sales up 10% and core operating income up. of 20%.
Read more
2024-10-04 (capage.in)
Novartis is Hiring a Senior Financial Analyst - GFMD
Novartis, a global leader in healthcare and pharmaceuticals, is looking for a Senior Financial Analyst to join its Global Financial Master Data (GFMD) team.
Read more
2024-10-04 (capage.in)
Novartis is Hiring a Senior Financial Analyst - GFMD
Novartis, a global leader in healthcare and pharmaceuticals, is looking for a Senior Financial Analyst to join its Global Financial Master Data (GFMD) team.
Read more
2024-09-20 (themarket.ch)
Thomas Bruhin: “The environment speaks for insurance stocks”
Thomas Bruhin, portfolio manager at Zürcher Kantonalbank, sees the stock market facing a balancing act between fantasies of interest rate cuts and economic developments.
Read more
2024-09-20 (themarket.ch)
Thomas Bruhin: “The environment speaks for insurance stocks”
Thomas Bruhin, portfolio manager at Zürcher Kantonalbank, sees the stock market facing a balancing act between fantasies of interest rate cuts and economic developments.
Read more
2024-09-20 (themarket.ch)
Thomas Bruhin: “The environment speaks for insurance stocks”
Thomas Bruhin, portfolio manager at Zürcher Kantonalbank, sees the stock market facing a balancing act between fantasies of interest rate cuts and economic developments.
Read more
2024-09-16 (etfdailynews.com)
Envestnet Asset Management Inc. Sells 24,199 Shares of Novartis AG (NYSE:NVS)
Envestnet Asset Management Inc. trimmed its stake in Novartis AG (NYSE:NVS – Free Report) by 1.2% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC).
Read more
2024-08-24 (wtaq.com)
Siemens Healthineers to buy Novartis unit for over $223 million, FT reports
(Reuters) - Siemens Healthineers will pay more than 200 million euros ($223.8 million) to acquire the diagnostic arm of Advanced Accelerator Applications, owned by Novartis, the Financial Times reported on Saturday. ($1 = 0.8937 euros) (Reporting ...
Read more
2024-08-24 (wtaq.com)
Siemens Healthineers to buy Novartis unit for over $223 million, FT reports
(Reuters) - Siemens Healthineers will pay more than 200 million euros ($223.8 million) to acquire the diagnostic arm of Advanced Accelerator Applications, owned by Novartis, the Financial Times reported on Saturday. ($1 = 0.8937 euros) (Reporting ...
Read more